LRRC2 Rekombinanter Antikörper
LRRC2 Rekombinant Antikörper für IHC, IF/ICC, FC (Intra), Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
IHC, IF/ICC, FC (Intra), Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
241132G1
Kat-Nr. : 84404-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
84404-1-PBS bindet in IHC, IF/ICC, FC (Intra), Indirect ELISA LRRC2 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | LRRC2 fusion protein Ag27830 |
| Vollständiger Name | leucine rich repeat containing 2 |
| Berechnetes Molekulargewicht | 371 aa, 43 kDa |
| GenBank-Zugangsnummer | BC029118 |
| Gene symbol | LRRC2 |
| Gene ID (NCBI) | 79442 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Leucine Rich Repeat Containing 2 (LRRC2) was found to be localized to the mitochondria in human cells and transcriptionally regulated by the mitochondrial master regulator Pgc-1α. It has been reported that Lrrc2 transcript abundance correlates with that of β-MHC, a canonical marker of cardiac hypertrophy in humans, and experimentally demonstrated an elevation in Lrrc2 transcript in vitro and in vivo rodent models of cardiac hypertrophy as well as in patients with dilated cardiomyopathy. (PMID: 28158196)









